Shenzhen New Industries Biomedical Engineering Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
35.42 | 69.4 | -48.96% | 0 | 0% |
| P/S |
|
15.31 | 6.51 | 135.28% |
|
|
| P/BV |
|
7.2 | 3.96 | 81.99% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
29.21 | 11.85 | 146.53% |
|
|
| Ev/S |
|
14.23 | 5.98 | 138.09% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0282 | 0.0396 | -28.78% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
45.91 | 20.39 | 125.18% | 50.95 | -9.88% |
| ROE |
|
21.67 | 11.95 | 81.41% |
|
|
| ROA |
|
12.34 | 5.4 | 128.45% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
43.08 | 16.23 | 165.4% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0016 | 14.63 | -99.99% | 0.0016 | +0% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.0017 | 3.6 | -99.95% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.83/10
|
1.13 | 1.83 | -38.35% | 0.9353 | +20.82% |
| Number of years of dividend growth |
|
2 | 1.44 | 39.13% | ||
| DSI |
|
0.9 | 0.9113 | -1.24% |
|
|
| Average dividend growth |
|
0.5222 | 10.4 | -94.98% |
|
|
| Average percentage for 5 years |
|
0.9353 | 1.14 | -18.1% |
|
|
| Average percentage for payments |
|
39.79 | 44.8 | -11.19% |
|
|
| Difference from average difference in sector |
|
-0.703 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
133.69 | 61.43 | 117.63% | ||
| Growth impulse Ebitda in 5 years |
|
90.81 | 158.62 | -42.75% | ||
| Growth impulse Net Income in 5 years |
|
114.03 | 66.93 | 70.37% | ||
| Growth impulse FCF in 5 years |
|
117.21 | 248.41 | -52.82% | ||
| Growth impulse EPS in 5 years |
|
27.04 | 73.29 | -63.11% |
IP Score
6.68/10
